ENO2 and neoplasm: In vivo studies have also confirmed the role of CA1, miR-125b-5p, miR-107, and NSE in tumor progression and chemoresistance as demonstrated by increased tumor sizes, migration, angiogenesis, and reduced sensitivity to chemotherapy [11,12,13,15].